Physician profile
Joy Y Chen
NPI 1104906908
$1,857.49
in general payments reported to CMS, 2019-2025
15 companies · $462 in 2025
The $462 reported for 2025 was less than what a typical Dermatology provider received nationally (typical 2025 total: $772).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $725 · 2020: $56.53 · 2021: $29.84 · 2022: $314 · 2023: $118 · 2024: $153 · 2025: $462.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $732.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $732.48 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $547.68 | 2019-2025 | |
| Nobel Biocare USA | $316.64 | 2022-2023 | Nobelactive |
| Allergan, INC. | $271.62 | 2019-2020 | |
| Galderma Laboratories, L.P. | $261.14 | 2019-2025 | Aklief |
| Genzyme Corporation | $112.25 | 2019-2025 | |
| Southern Implants North America INC | $100.20 | 2022 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $62.15 | 2019 | |
| Pfizer INC. | $39.30 | 2019 | |
| Regeneron Healthcare Solutions, INC. | $35.28 | 2019 | |
| Celgene Corporation | $27.46 | 2019 | |
| Mayne Pharma Commercial LLC | $25.92 | 2019 | |
| Zimmer Biomet Holdings, INC. | $17.99 | 2021 | |
| Almirall LLC | $14.14 | 2019 | |
| Merck Sharp & Dohme LLC | $13.52 | 2019 | |
| Mylan Pharmaceuticals INC. | $12.20 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joy Chen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.